NEW YORK, Aug. 21, 2020 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), today announced …
Read More »Leo Pharma and Elektrofi Enter Exclusive License Agreement to Develop Monoclonal Antibodies Using Elektrofi’s High-Concentration, Low-Volume Delivery Technology
BOSTON & BALLERUP, Denmark–(BUSINESS WIRE)–Elektrofi, Inc., a Boston-based biotechnology company focused on drug formulation and …
Read More »